EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
28/04/2026
Voltar para busca
Dado oficial do USPTO
ARUP CONSULT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
30/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
44
Data de depósito
20/04/2006
Data de registro
26/08/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/09/2018
Última transação
30/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
29/09/2006
Primeiro uso no comércio
29/09/2006
Código do desenho
4
Tipo de titular
03
Localização do titular
SALT LAKE CITY, UT, US
Examinador
MICHOS, JOHN E
Unidade examinadora
L50
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
ARUP LABORATORIES, INC.
Associated Regional and University Pathologists, Inc.
Representantes
Lester K. Essig Ray Quinney & Nebeker
Classificação técnica
Classes Nice
Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 44
Providing medical information online to pathologistsphysicians and other healthcare practitioners over a global communications networkthrough handheld electronic devices and other meanswith respect to teststest resultstest analysistest trendstest effectivenesstest advisabilitytest selectiontest orderingtest ordering managementtest ordering procedurestest ordering efficiencytest ordering effectivenessutilization management servicesmedical conditionhealth conditiondiagnosis in the fields of pathologyclinical pathologyanatomic pathologyhistopathologyhistologyinfectious diseasesdisease pathologyinfectious disease pathologystaining analysisvirologyhematopathologyhematologyproteomicshemostasisthrombosisflow analysisflow cytometrycapillary electrophoresisgeneticsmolecular geneticsbiochemical geneticsgenetic diseasesgene identificationgene sequencingnucleotide sequencinggenotypic identificationphenotypic identificationprobe synthesisgene therapymass spectrometrytandem mass spectrometrymolecular testingmolecular diagnosticsmolecular evaluationcytopathologycytologycytogeneticsoncologytumor detectiontumor markerstumor diagnosticsmutation detectionmutation analysismorphologic changeimmunopathologyimmunologyimmunohematologyimmunohistochemical stainingimmunofluorescenceautoimmune disordersmicrobiologyserologymicrobial serologyendocrinologyclinical chemistrytoxicologyclinical toxicologytoxinspharmacogenomicstherapeutic drugstransplantation pathologysurgical pathologyautopsy pathologymetabolicsmetabolic statusnutritional statusmicrowave processingmicroscopyelectron microscopycore lab testingengineering analysislaboratory automationmedical informaticshealth carechild health care; and evaluating dataidentifying trendsdesigning reportsreportingdelivering reports and making recommendations with respect to test resultstest analysistest trendstest efficiencytest effectivenesstest advisabilitytest selectiontest orderingtest ordering managementtest ordering procedurestest ordering efficiencytest ordering effectivenessutilization management servicesmedical conditionhealth conditiondiagnosis in the fields of pathologyclinical pathologyanatomic pathologyhistopathologyhistologyinfectious diseasesdisease pathologyinfectious disease pathologystaining analysisvirologyhematopathologyhematologyproteomicshemostasisthrombosisflow analysisflow cytometrycapillary electrophoresisgeneticsmolecular geneticsbiochemical geneticsgenetic diseasesgene identificationgene sequencingnucleotide sequencinggenotypic identificationphenotypic identificationprobe synthesisgene therapymass spectrometrytandem mass spectrometrymolecular testingmolecular diagnosticsmolecular evaluationcytopathologycytologycytogeneticsoncologytumor detectiontumor markerstumor diagnosticsmutation detectionmutation analysismorphologic changeimmunopathologyimmunologyimmunohematologyimmunohistochemical stainingimmunofluorescenceautoimmune disordersmicrobiologyserologymicrobial serologyendocrinologyclinical chemistrytoxicologyclinical toxicologytoxinspharmacogenomicstherapeutic drugstransplantation pathologysurgical pathologyautopsy pathologymetabolicsmetabolic statusnutritional statusmicrowave processingmicroscopyelectron microscopycore lab testingengineering analysislaboratory automationmedical informaticshealth carechild health care
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/04/2026
CCON
COUNTERCLAIM OPP. NO. 999999
07/05/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/09/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/09/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/09/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
24/08/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
11/09/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/09/2014
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
27/08/2014
PAPER RECEIVED
27/08/2014
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
20/03/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
22/07/2008
ALIE
ASSIGNED TO LIE
21/07/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/07/2008
SUPC
STATEMENT OF USE PROCESSING COMPLETE
14/06/2008
PAPER RECEIVED
29/05/2008
IUAF
USE AMENDMENT FILED
27/05/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
27/11/2007
PUBO
PUBLISHED FOR OPPOSITION
04/09/2007
NPUB
NOTICE OF PUBLICATION
15/08/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
27/07/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/07/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
05/07/2007
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/07/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/05/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
27/04/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/04/2007
ALIE
ASSIGNED TO LIE
27/04/2007
PAPER RECEIVED
28/03/2007
CNRT
NON-FINAL ACTION MAILED
26/09/2006
CNRT
NON-FINAL ACTION WRITTEN
26/09/2006
DOCK
ASSIGNED TO EXAMINER
25/09/2006
NWAP
NEW APPLICATION ENTERED
26/04/2006
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ARUP CONSULT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.